Cotinga Pharmaceuticals Forward P/E
What is the Forward P/E of Cotinga Pharmaceuticals?
The Forward P/E of Cotinga Pharmaceuticals, Inc. is -1.63
What is the definition of Forward P/E?
Forward price to earnings ratio is the ratio of a company’s stock price to the company’s estimated earnings per share for the next twelve months.
The forward price to earnings ratio is similar to trailing price to earnings ratio but instead of net income uses estimated net earnings over next 12 months. Estimates are typically derived as the mean of those published by a select group of analysts with selection criteria varying. The forward price-to-earnings ratio is a powerful, but limited tool. It allows a quick snapshot of the company’s finances without getting down in the details of an accounting report.
Forward P/E of companies in the Health Care sector on TSXV compared to Cotinga Pharmaceuticals
What does Cotinga Pharmaceuticals do?
Cotinga Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer and other unmet medical needs. The company's lead compound is COTI-2, an oral small molecule targeting p53 a tumor suppressor gene. It also develops COTI-219, an oral small molecule compound targeting the mutant forms of KRAS without inhibiting normal KRAS functions. Cotinga Pharmaceuticals Inc. has a research collaboration with St. Vincent's University Hospital to evaluate COTI-2 in combination with eribulin in patients with triple negative metastatic breast cancer. The company was formerly known as Critical Outcome Technologies Inc. and changed its name to Cotinga Pharmaceuticals Inc. in January 2018. Cotinga Pharmaceuticals Inc. is based in Toronto, Canada.
Companies with forward p/e similar to Cotinga Pharmaceuticals
- Allogene Therapeutics Inc has Forward P/E of -1.74
- Applied Dna Sciences Inc has Forward P/E of -1.72
- Resaas Services has Forward P/E of -1.70
- Contact Gold has Forward P/E of -1.67
- FAT Brands Inc has Forward P/E of -1.66
- T2 Biosystems Inc has Forward P/E of -1.64
- Cotinga Pharmaceuticals has Forward P/E of -1.63
- Osmotica Pharmaceuticals Plc has Forward P/E of -1.61
- Black Diamond Therapeutics Inc has Forward P/E of -1.59
- Proteostasis Therapeutics Inc has Forward P/E of -1.57
- Hepion Pharmaceuticals Inc has Forward P/E of -1.56
- Suzlon has Forward P/E of -1.53
- Acasti Pharma has Forward P/E of -1.51